Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Ordspono (odronextamab) has been ...

The GLORIOUS trial found that an intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) during heart surgeries ...

First, on May 15 of this year, it was approved by the FDA for the treatment of certain patients with relapsed/refractory ...

Paris: Sanofi has announced that the European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) ...

Earlier in 2019 Sanofi also paid Regeneron $462 million to exit from an immuno-oncology alliance formed in 2015, and in 2017 said they would end discovery research in new antibody drugs.

Prime Minister Narendra Modi arrived in Nigeria on Sunday, marking the first visit by an Indian Prime Minister in 17 years. He will receive the Grand Commander of the Order of the Niger (GCON ...

The November 17 Polytechnic uprising anniversary in Athens, once a symbol of resistance against the Greek military junta, is now often overshadowed by clashes between police and far-left groups.

The father of two was allegedly attacked while waiting for a ride home.